Suppr超能文献

相似文献

引用本文的文献

1
Features and therapeutic potential of T-cell receptors in high-grade glioma.
Chin Med J (Engl). 2019 Jun 20;132(12):1435-1440. doi: 10.1097/CM9.0000000000000282.
2
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
Semin Immunopathol. 2017 Apr;39(3):255-268. doi: 10.1007/s00281-016-0614-9. Epub 2017 Jan 10.
3
Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.
Cancers (Basel). 2011 Jul 18;3(3):2904-54. doi: 10.3390/cancers3032904.
4
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
Cancer Immunol Immunother. 2011 Aug;60(8):1153-60. doi: 10.1007/s00262-011-1026-2. Epub 2011 May 7.
5
CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.
Clin Exp Immunol. 2006 Jan;143(1):93-102. doi: 10.1111/j.1365-2249.2005.02972.x.
6
Mouse models of efficient and inefficient anti-tumor immunity, with emphasis on minimal residual disease and tumor escape.
Cancer Immunol Immunother. 2006 Jan;55(1):1-22. doi: 10.1007/s00262-005-0007-8. Epub 2005 Oct 27.
8
T-cell clonotypes in cancer.
J Transl Med. 2004 Apr 8;2(1):11. doi: 10.1186/1479-5876-2-11.
10
T cell receptor usage in malignant diseases.
Springer Semin Immunopathol. 1999;21(1):19-35. doi: 10.1007/BF00815176.

本文引用的文献

1
Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses.
Immunol Today. 1995 Dec;16(12):588-95. doi: 10.1016/0167-5699(95)80082-4.
3
HLA Class I nucleotide sequences, 1992.
Immunobiology. 1993 Jan;187(1-2):70-101. doi: 10.1016/S0171-2985(11)80246-9.
9
Maintenance of clonal anergy by endogenously produced IL-10.
Int Immunol. 1994 Oct;6(10):1605-12. doi: 10.1093/intimm/6.10.1605.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验